Trevi Therapeutics (TRVI) Stock Insights
$1.93B
Market Cap
-37.33
P/E
—
Forward P/E
67
Score
TRVI price $13.52 +0.17 +1.27%
Stocklytics score rationale: value 53, quality 47, growth 100.
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the advancement and commercialization of Haduvio, a potential treatment for debilitating neurologically mediated conditions. This orally administered, extended-release formulation of nalbuphine is currently undergoing Phase IIb/III clinical trials for chronic pruritus (severe itching) and persistent cough experienced by patients with…
TRVI fair value Not meaningful. Price $13.52.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Not meaningful
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-12 | — | -0.13 | — | — |
| 2026-08-06 | -0.11 | -0.11 | — | — |
| 2026-05-05 | -0.09 | -0.07 | — | — |
| 2026-03-17 | -0.06 | -0.10 | — | — |
| 2025-11-13 | -0.08 | -0.10 | — | — |
| 2025-08-07 | -0.09 | -0.10 | — | — |
| 2025-05-08 | -0.09 | -0.13 | — | — |
| 2025-03-18 | -0.11 | -0.12 | — | — |
| 2024-11-06 | -0.13 | -0.12 | — | — |
| 2024-08-08 | -0.12 | -0.11 | — | — |
| 2024-05-07 | -0.11 | -0.09 | — | — |
| 2024-03-20 | -0.08 | -0.10 | 176.00K | — |
| 2023-11-09 | -0.08 | -0.09 | — | — |
| 2023-08-10 | -0.07 | -0.09 | — | — |
| 2023-05-11 | -0.06 | -0.08 | — | — |
| 2023-03-16 | -0.06 | -0.11 | — | — |
| 2022-11-10 | -0.12 | -0.15 | — | — |
| 2022-08-11 | -0.14 | -0.21 | — | — |
| 2022-05-12 | -0.24 | -0.31 | — | — |
| 2022-03-17 | -0.28 | -0.34 | — | — |
| 2021-11-10 | -0.34 | -0.33 | — | — |
| 2021-08-12 | -0.49 | -0.46 | — | — |
| 2021-05-13 | -0.43 | -0.49 | — | — |
| 2021-03-25 | -0.52 | -0.45 | — | — |
| 2020-11-12 | -0.41 | -0.59 | — | — |
| 2020-08-13 | -0.41 | -0.52 | — | — |
| 2020-05-07 | -0.48 | -0.44 | — | — |
| 2020-03-16 | -0.19 | -0.51 | — | — |
| 2019-11-14 | -0.41 | -0.48 | — | — |
| 2019-08-12 | -0.63 | -0.41 | — | — |
| 2019-06-13 | -13.85 | -0.52 | — | — |
| 2019-05-08 | -0.34 | — | — | — |
| 2018-09-30 | -0.63 | — | — | — |
| 2018-06-30 | -0.54 | — | — | — |
| 2018-03-31 | -0.45 | — | — | — |
| 2017-12-31 | -8.05 | — | — | — |
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-09-15 | Heffernan Michael Thomas | Buy | 21.05K | $3.33 | 70.10K |
| 2026-09-15 | Heffernan Michael Thomas | Buy | 18.42K | $3.04 | 56.00K |
| 2026-09-15 | Heffernan Michael Thomas | Sell | 20.95K | $15.09 | 316.17K |
| 2026-09-15 | Heffernan Michael Thomas | Sell | 100 | $15.88 | 1.59K |
| 2026-09-15 | Heffernan Michael Thomas | Sell | 18.42K | $3.04 | 56.00K |
| 2026-09-15 | Heffernan Michael Thomas | Sell | 21.05K | $3.33 | 70.10K |
| 2026-06-03 | Mathers Edward T | Buy | 35.00K | $13.45 | 470.75K |
| 2026-06-03 | Colangelo Dominick | Buy | 35.00K | $13.45 | 470.75K |
| 2026-06-03 | Meeker David P | Buy | 35.00K | $13.45 | 470.75K |
| 2026-06-03 | VANLENT ANNE | Buy | 35.00K | $13.45 | 470.75K |
| 2026-06-03 | Heffernan Michael Thomas | Buy | 35.00K | $13.45 | 470.75K |
| 2026-02-19 | Cassella James V | Buy | 215.00K | $10.56 | 2.27M |
| 2026-02-19 | Galletta Christopher | Buy | 35.00K | $10.56 | 369.60K |
| 2026-02-19 | SCIASCIA THOMAS | Buy | 85.00K | $10.56 | 897.60K |
| 2026-02-19 | GOOD JENNIFER L | Buy | 675.00K | $10.56 | 7.13M |
| 2026-02-19 | Simon Farrell | Buy | 160.00K | $10.56 | 1.69M |
| 2026-01-08 | HASTINGS DAVID C | Buy | 375.00K | $11.21 | 4.20M |
| 2026-01-08 | HASTINGS DAVID C | Other | 0 | — | — |
| 2025-12-31 | Florence Anthony A. Jr. | Other | 0 | — | — |
| 2025-12-31 | SANDELL SCOTT D | Other | 0 | — | — |
| 2025-12-31 | Behbahani Ali | Other | 0 | — | — |
| 2025-12-31 | Makhzoumi Mohamad | Other | 0 | — | — |
| 2025-12-31 | Walker Paul Edward | Other | 0 | — | — |
| 2025-12-31 | Chang Carmen | Other | 0 | — | — |
| 2025-12-02 | Galletta Christopher | Buy | 4.22K | $0.51 | 2.16K |
| 2025-12-02 | Galletta Christopher | Sell | 4.22K | $0.51 | 2.16K |
| 2025-06-11 | Mathers Edward T | Buy | 45.00K | $6.25 | 281.25K |
| 2025-06-11 | Colangelo Dominick | Buy | 45.00K | $6.25 | 281.25K |
| 2025-06-11 | Heffernan Michael Thomas | Buy | 45.00K | $6.25 | 281.25K |
| 2025-06-11 | VANLENT ANNE | Buy | 45.00K | $6.25 | 281.25K |
| 2025-06-11 | Meeker David P | Buy | 45.00K | $6.25 | 281.25K |
| 2025-05-31 | Galletta Christopher | Buy | 8.55K | $2.38 | 20.35K |
| 2025-05-31 | SCIASCIA THOMAS | Buy | 60.00K | $2.38 | 142.80K |
| 2025-05-31 | Delfini Lisa | Buy | 72.00K | $2.38 | 171.36K |
| 2025-05-31 | Simon Farrell | Buy | 72.00K | $2.38 | 171.36K |
| 2025-05-31 | GOOD JENNIFER L | Buy | 102.00K | $2.38 | 242.76K |
| 2025-04-17 | SANDELL SCOTT D | Buy | 1.85M | $1.37 | 2.54M |
| 2025-04-17 | Florence Anthony A. Jr. | Buy | 1.85M | $1.37 | 2.54M |
| 2025-04-17 | SANDELL SCOTT D | Sell | 1.85M | $1.37 | 2.54M |
| 2025-04-17 | Florence Anthony A. Jr. | Sell | 1.85M | $1.37 | 2.54M |
| 2025-04-17 | Behbahani Ali | Buy | 1.85M | $1.37 | 2.54M |
| 2025-04-17 | Behbahani Ali | Sell | 1.85M | $1.37 | 2.54M |
| 2025-04-17 | BASKETT FOREST | Buy | 1.85M | $1.37 | 2.54M |
| 2025-04-17 | BASKETT FOREST | Sell | 1.85M | $1.37 | 2.54M |
| 2025-04-17 | Makhzoumi Mohamad | Buy | 1.85M | $1.37 | 2.54M |
| 2025-04-17 | Makhzoumi Mohamad | Sell | 1.85M | $1.37 | 2.54M |
| 2025-04-17 | Walker Paul Edward | Buy | 1.85M | $1.37 | 2.54M |
| 2025-04-17 | Walker Paul Edward | Sell | 1.85M | $1.37 | 2.54M |
| 2025-04-17 | New Enterprise Associates 16, L.P. | Buy | 1.85M | $1.37 | 2.54M |
| 2025-04-17 | New Enterprise Associates 16, L.P. | Sell | 1.85M | $1.37 | 2.54M |
| 2025-04-17 | Chang Carmen | Buy | 1.85M | $1.37 | 2.54M |
| 2025-04-17 | Chang Carmen | Sell | 1.85M | $1.37 | 2.54M |
| 2025-03-25 | SCIASCIA THOMAS | Buy | 2.63K | $1.43 | 3.76K |
| 2025-03-25 | SCIASCIA THOMAS | Sell | 2.63K | $6.60 | 17.36K |
| 2025-03-25 | SCIASCIA THOMAS | Sell | 2.63K | $1.43 | 3.76K |
| 2025-03-21 | GOOD JENNIFER L | Buy | 5.26K | $1.43 | 7.53K |
| 2025-03-21 | GOOD JENNIFER L | Sell | 5.26K | $6.58 | 34.62K |
| 2025-03-21 | GOOD JENNIFER L | Sell | 5.26K | $1.43 | 7.53K |
| 2025-03-10 | GOOD JENNIFER L | Buy | 54.40K | $2.38 | 129.47K |
| 2025-03-10 | Delfini Lisa | Buy | 38.40K | $2.38 | 91.39K |
| 2025-03-10 | SCIASCIA THOMAS | Buy | 32.00K | $2.38 | 76.16K |
| 2025-03-10 | Galletta Christopher | Buy | 4.56K | $2.38 | 10.85K |
| 2025-03-10 | Simon Farrell | Buy | 31.25K | $0.51 | 15.97K |
| 2025-03-10 | Simon Farrell | Buy | 63.81K | $3.91 | 249.51K |
| 2025-03-10 | Simon Farrell | Sell | 76.96K | $6.73 | 517.78K |
| 2025-03-10 | Simon Farrell | Sell | 4.35K | $7.15 | 31.10K |
| 2025-03-10 | Simon Farrell | Buy | 17.50K | $3.21 | 56.17K |
| 2025-03-10 | Simon Farrell | Buy | 38.40K | $2.38 | 91.39K |
| 2025-03-10 | Simon Farrell | Sell | 31.25K | $0.51 | 15.97K |
| 2025-03-10 | Simon Farrell | Sell | 63.81K | $3.91 | 249.51K |
| 2025-03-10 | Simon Farrell | Sell | 17.50K | $3.21 | 56.17K |
| 2025-02-18 | SCIASCIA THOMAS | Buy | 116.00K | $4.22 | 489.52K |
| 2025-02-18 | Cassella James V | Buy | 257.50K | $4.22 | 1.09M |
| 2025-02-18 | Simon Farrell | Buy | 225.50K | $4.22 | 951.61K |
| 2025-02-18 | Delfini Lisa | Buy | 225.50K | $4.22 | 951.61K |
| 2025-02-18 | GOOD JENNIFER L | Buy | 811.00K | $4.22 | 3.42M |
| 2025-02-18 | Galletta Christopher | Buy | 41.00K | $4.22 | 173.02K |
| 2025-01-08 | Delfini Lisa | Buy | 5.00K | $0.51 | 2.56K |
| 2025-01-08 | Delfini Lisa | Sell | 5.00K | $0.51 | 2.56K |
| 2025-01-07 | Delfini Lisa | Buy | 1.00K | $0.51 | 511 |
| 2025-01-07 | Delfini Lisa | Sell | 1.00K | $0.51 | 511 |
| 2024-12-13 | Galletta Christopher | Sell | 15.00K | $0.51 | 7.67K |
| 2024-12-13 | Galletta Christopher | Buy | 15.00K | $0.51 | 7.67K |
| 2024-09-30 | Cassella James V | Buy | 400.00K | $3.34 | 1.34M |
| 2024-09-09 | GOOD JENNIFER L | Buy | 1.84K | $1.43 | 2.63K |
| 2024-09-09 | GOOD JENNIFER L | Sell | 1.84K | $3.04 | 5.59K |
| 2024-09-09 | GOOD JENNIFER L | Sell | 1.84K | $1.43 | 2.63K |
| 2024-09-06 | GOOD JENNIFER L | Buy | 4.22K | $1.43 | 6.03K |
| 2024-09-06 | GOOD JENNIFER L | Sell | 4.22K | $3.03 | 12.78K |
| 2024-09-06 | GOOD JENNIFER L | Sell | 4.22K | $1.43 | 6.03K |
| 2024-09-05 | GOOD JENNIFER L | Buy | 40.28K | $1.43 | 57.60K |
| 2024-09-05 | GOOD JENNIFER L | Sell | 40.28K | $3.11 | 125.31K |
| 2024-09-05 | GOOD JENNIFER L | Sell | 40.28K | $1.43 | 57.60K |
| 2024-09-04 | GOOD JENNIFER L | Buy | 10.98K | $1.43 | 15.70K |
| 2024-09-04 | GOOD JENNIFER L | Sell | 10.98K | $3.02 | 33.21K |
| 2024-09-04 | GOOD JENNIFER L | Sell | 10.98K | $1.43 | 15.70K |
| 2024-09-03 | GOOD JENNIFER L | Buy | 3.86K | $1.43 | 5.52K |
| 2024-09-03 | GOOD JENNIFER L | Sell | 3.86K | $3.02 | 11.68K |
| 2024-09-03 | GOOD JENNIFER L | Sell | 3.86K | $1.43 | 5.52K |
| 2024-08-27 | Meeker David P | Buy | 4.55K | $1.43 | 6.51K |
Latest filed quarter: Q2 2026.
Institutions holding: 226, holders +21 vs prior quarter. Ownership 95.79%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| NEA MANAGEMENT COMPANY, LLC | 13.22M | 0 | 0.00% | 246.59M |
| FMR LLC | 12.56M | 4.52M | +56.29% | 234.30M |
| BLACKROCK, INC. | 11.16M | 914.84K | +8.93% | 208.04M |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 9.94M | -100 | -0.00% | 185.37M |
| WELLINGTON MANAGEMENT GROUP LLP | 5.68M | 495.50K | +9.55% | 106.02M |
| VANGUARD CAPITAL MANAGEMENT LLC | 5.53M | 552.11K | +11.09% | 103.15M |
| VIVO CAPITAL, LLC | 5.09M | 0 | 0.00% | 95.02M |
| WOODLINE PARTNERS LP | 4.08M | 3.08M | +307.81% | 76.12M |
| VESTAL POINT CAPITAL, LP | 3.10M | 933.50K | +43.09% | 57.81M |
| MPM BIOIMPACT LLC | 3.07M | -224.85K | -6.82% | 57.32M |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 3.07M | 1.08M | +53.98% | 57.27M |
| STATE STREET CORP | 3.03M | 362.00K | +13.58% | 56.46M |
| GEODE CAPITAL MANAGEMENT, LLC | 2.93M | 149.84K | +5.39% | 54.62M |
| MARSHALL WACE, LLP | 2.67M | -1.29M | -32.57% | 49.87M |
| EVENTIDE ASSET MANAGEMENT, LLC | 2.66M | 37.69K | +1.44% | 49.61M |
| RUBRIC CAPITAL MANAGEMENT LP | 2.50M | -1.21M | -32.54% | 46.71M |
| ARTIA GLOBAL PARTNERS LP | 2.21M | 197.25K | +9.80% | 41.23M |
| ACORN CAPITAL ADVISORS, LLC | 2.14M | 0 | 0.00% | 40.00M |
| FIRST LIGHT ASSET MANAGEMENT, LLC | 2.10M | 2.10M | New | 39.11M |
| PICTET ASSET MANAGEMENT HOLDING SA | 2.01M | 307.74K | +18.04% | 37.56M |
| LOGOS GLOBAL MANAGEMENT LP | 1.88M | -520.00K | -21.67% | 35.06M |
| AFFINITY ASSET ADVISORS, LLC | 1.80M | -200.00K | -10.00% | 33.57M |
| EMERALD ADVISERS, LLC | 1.80M | -41.95K | -2.28% | 33.53M |
| SIREN, L.L.C. | 1.79M | 0 | 0.00% | 33.33M |
| PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC | 1.74M | 188.95K | +12.16% | 32.50M |
Insights · Dividends · Forecast · Financials · Learn
$1.93B
Market Cap
-37.33
P/E
—
Forward P/E
67
Score